Clinical Trial Update: Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of lenalidomide plus epcoritamab for previously untreated follicular lymphoma is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• EPKINLY (EPCORITAMAB-BYSP)
• Revlimid (lenalidomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Follicular Lymphoma | Phase 2 | Status: SUSPENDED